Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1001 of 5804
-
Scientists map cellular secrets of recurring colon polyps to prevent future cancer
Knowledge-focused Not yet recruitingWe aim to establish a single-cell atlas of primary adenomas, recurrent adenomas, and paired normal mucosa, identify recurrence-associated cell subpopulations and transcriptional pathways, and construct a risk prediction model for recurrence (integrating multi-omics features and c…
Sponsor: Zhongshan Hospital Xiamen University • Aim: Knowledge-focused
Last updated Jul 08, 2026 00:00 UTC
-
Second dose of experimental drug may help when first fails
Disease control Recruiting nowThis study is intended to explore the efficacy and safety of a second course of ianalumab after experiencing treatment failure in the pivotal Primary Immune Thrombocytopenia (ITP) trials (CVAY736I12301, CVAY736Q12301) and after loss of durable response in the pivotal Warm Autoimm…
Phase: PHASE2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
Can a new protein drug shield kids with cancer from dangerous infections?
Disease control Recruiting nowQLC2519 (Mai Li Sheng®) is a new protein drug created by fusing the N-terminal of highly active modified G-CSF with the C-terminal of HSA. The modified G-CSF retained high activity while reducing affinity for the G-CSF receptor, which can significantly inhibit the the G-CSF recep…
Phase: PHASE2 • Sponsor: Qilu Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
New triple inhaler aims to tame uncontrolled asthma
Disease control Recruiting nowThis is a study comparing CHF 5993 pMDI HFA-152a with CHF 1535 pMDI HFA-134a in Chinese patients with asthma uncontrolled on medium doses of ICS+LABA.
Phase: PHASE3 • Sponsor: Chiesi Farmaceutici S.p.A. • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
New asthma shot could help kids breathe easier
Disease control Not yet recruitingThis study is aimed at assessing depemokimab as an add-on medicine for the treatment of asthma with type-2 inflammation in participants of 6 to 11 years of age. This study will test how the body processes depemokimab, how the drug works in the body, and its safety and tolerabilit…
Phase: PHASE3 • Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC
-
Mapping Cancer's next move: study tracks where prostate cancer returns after aggressive radiotherapy
Knowledge-focused Recruiting nowThis is an ambispective, multicenter, observational real-world registry of patients with synchronous de novo oligometastatic prostate cancer, defined as prostate cancer with up to 10 extraregional metastatic lesions diagnosed at initial presentation or within 6 months of the prim…
Sponsor: Affidea Nu-med Center of Oncological DIagnostics and Therapy • Aim: Knowledge-focused
Last updated Jul 08, 2026 00:00 UTC
-
New antibody aims to neutralize allergies by clearing IgE
Disease control Recruiting nowThis is a Phase 1combined single ascending dose (SAD)/multiple ascending dose (MAD) randomized, double-blind, placebo-controlled trial to assess the safety, tolerability, pharmacokinetics, pharmacodynamics, and immunogenicity of single and multiple ascending subcutaneous doses of…
Phase: PHASE1 • Sponsor: Lycia Therapeutics, Inc. • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
Ear-Clip nerve zaps may wake hidden awareness after brain injury
Symptom relief Recruiting nowSome patients with severe traumatic brain injury cannot respond at the bedside, yet about 1 in 4 may be aware but unable to show it - a hidden state called cognitive motor dissociation. This study tests a gentle, non-invasive treatment delivered through clips on the left ear that…
Phase: NA • Sponsor: Sima Mofakham • Aim: Symptom relief
Last updated Jul 24, 2026 00:00 UTC
-
Can immune markers predict breast cancer treatment success?
Knowledge-focused Recruiting nowThe goal of this clinical trial is to identify cellular and molecular determinants of response to neoadjuvant immunochemotherapy in women aged 18 or older with early-stage triple-negative breast cancer (TNBC). The main questions it aims to answer are: * Can detailed immune profi…
Sponsor: Center Eugene Marquis • Aim: Knowledge-focused
Last updated Jul 12, 2026 00:00 UTC
-
Could LVAD patients ditch aspirin? new trial aims to find out
Disease control Not yet recruitingThis multi-center, prospective, randomized, double-blinded, placebo-controlled study aims to investigate whether withdrawal of aspirin from the antithrombotic regimen in patients supported with the CH-VAD pump is non-inferior to the standard antithrombotic regimen of vitamin K an…
Phase: PHASE4 • Sponsor: China National Center for Cardiovascular Diseases • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
New DNA vaccine aims to clear Cancer-Causing HPV
Disease control Recruiting nowThis research is being done to test the safety and feasibility of an investigational DNA vaccine called pBI-11 and to find out what effects, if any, it has on women with persistent human papillomavirus 16 (HPV16+) and/or human papillomavirus (HPV18+) cervical infection. The DNA …
Phase: PHASE2 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Can a better vitamin mix beat iron pills for anemia in pregnancy?
Disease control Not yet recruitingThis study aims to compare the effectiveness of Multiple Micronutrient Supplementation (MMS), Iron-Folic Acid (IFA) supplementation, and combined MMS+IFA supplementation among pregnant women. Maternal anemia and micronutrient deficiencies are common during pregnancy and can adver…
Phase: NA • Sponsor: Sindh Institute of Child Health and Neonatology • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
New anesthetic may protect frail elderly from dangerous blood pressure drops during surgery
Disease control Not yet recruitingPost-induction hypotension (PIH) is a common and critical complication during general anesthesia, particularly in frail elderly patients whose physiological reserves are significantly diminished. PIH is strongly associated with adverse postoperative outcomes, including acute kidn…
Phase: NA • Sponsor: General Hospital of Ningxia Medical University • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
New hope for thalassemia patients: drug may cut blood transfusions
Disease control Recruiting nowThe purpose of this study is to evaluate luspatercept treatment in adults with transfusion-dependent beta-Thalassemia in the Middle East
Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Texts after trauma: new study tests simple tools to prevent PTSD and opioid abuse
Symptom relief ENROLLING_BY_INVITATIONThe goal of this clinical trial is to learn whether a video given for recent sexual assault survivors and/or a 3-week text messaging intervention with similar content is effective at reducing mental health problems and substance misuse following the assault.
Phase: NA • Sponsor: University of Wisconsin, Madison • Aim: Symptom relief
Last updated Jul 09, 2026 00:00 UTC
-
Could a whisper in your ear treat sleep apnea?
Disease control Recruiting nowPatients with obstructive sleep apnea (OSA) often experience more frequent and severe breathing disturbances when sleeping in the supine (back-sleeping) position compared with non-supine positions. Positional therapy aims to reduce time spent sleeping in the supine position, but …
Phase: NA • Sponsor: SleepDev, Inc • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
Gene therapy injection aims to save sight in rare eye disease
Disease control Not yet recruitingThis is a Phase 1/2, multi-center, randomized, sham-controlled, dose-escalation study evaluating ZM-02 in patients with advanced retinitis pigmentosa (RP).
Phase: PHASE1, PHASE2 • Sponsor: Zhongmou Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
Pregnant women with hepatitis c get new hope in drug trial
Disease control Recruiting nowThis is a Phase I/II, multi-site, open-label, single arm study to describe the pharmacokinetics (PK) and safety of glecaprevir/pibrentasvir (GLE/PIB) initiated during pregnancy in women with hepatitis C virus (HCV) infection (acute or chronic) with or without HIV and to evaluate …
Phase: PHASE1, PHASE2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Virtual peer mentoring aims to boost cervical cancer screening in ethiopian HIV clinics
Knowledge-focused ENROLLING_BY_INVITATIONProject TICHILALECH ("she can" in Amharic), a five-year, implementation science study, is focused on improving cervical cancer screening, triage, and treatment and integration with human immunodeficiency virus (HIV) care at five Ethiopian hospitals, with a focus on human papillom…
Phase: NA • Sponsor: Albert Einstein College of Medicine • Aim: Knowledge-focused
Last updated Jul 03, 2026 00:00 UTC
-
New cocktail of charcoal and laxative could speed up poison recovery
Disease control Recruiting nowGastrointestinal absorption of high dose medication (toxicant) ingested under solid form for suicidal purposes, is prolonged in patients who need intensive care admission and mechanical ventilation. This is due to the large ingested amounts, slowed blood circulation in the digest…
Phase: PHASE2 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC